Timeline of Amelogenesis Imperfecta Management

Area of Science:

• Dental genetics
• Rare diseases
• Orodental health

Background:

• Amelogenesis imperfecta (AI) encompasses over 100 rare genetic conditions affecting tooth enamel development.
• Patients and families experience significant diagnostic delays and a fragmented therapeutic journey.
• Multidisciplinary management is crucial throughout a patient's life, from childhood to adulthood.

Purpose of the Study:

• To define the roles of healthcare professionals involved in managing Amelogenesis imperfecta.
• To establish guidelines and timelines for critical intervention periods.
• To enhance the overall care and management strategies for AI patients.

Main Methods:

• Review of current clinical and genetic diagnostic approaches for AI.
• Description of the multidisciplinary team's responsibilities.
• Development of proposed management timelines based on expert consensus from the ERN CRANIO Orodental group.

Main Results:

• Detailed outline of the specific contributions of various health professionals (e.g., geneticists, dentists, therapists).
• Identification of key developmental and intervention milestones.
• Framework for improved coordination of care across different specialties.

Conclusions:

• Standardized roles and timely interventions are essential for optimizing Amelogenesis imperfecta management.
• Effective multidisciplinary collaboration improves diagnostic accuracy and therapeutic outcomes.
• Guidelines provided aim to reduce patient 'treatment odyssey' and improve quality of life.